Form 4 for TSHA Taysha Gene Therapies, Inc.
Accepted 2024-02-06 00:00:00 ET · period of report 2024-02-02 · accession 0001415889-24-002809 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-06 | 2024-02-02 | TSHA | Alam Kamran | CFO | F - Tax | $1.51 | -1,288 | 840.9K | -0.2% | -$1,945 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-02 | F | D | 1,288 | $1.51 | 840,937 | D | — | — |